The plan is to launch versions of United Therapeutics’ drugs into orbit, where they can be allowed to form solid crystals.

On track for August 2026 top-line results from Phase 2b clinical trial (ELPIS II) evaluating laromestrocel as a potential adjunct treatment for ...

Aecom has finished the 4km-long eastern section of the Fanling Bypass, the first major transport project delivered in Hong ...

Seer, Inc. ( SEER) Q1 2026 Earnings Call May 13, 2026 4:30 PM EDT Good day, and welcome to Seer First Quarter 2026 Earnings Conference Call. [Operator Instructions] Please note this event is being ...

Minister of Environment Julie Dabrusin has announced a $2.4 million investment to study the impact of plastic pollution on ...

Live webcasts of the presentations will be available by selecting Events and Presentations under the News & Events tab in the Investors section on www.candeltx.com. A replay of the webcasts will be ...

As large medical imaging datasets become widely available, researchers are increasingly turning to artificial intelligence to ...

A new study shows that a simple measurement from routine chest X-rays can help predict survival among patients with lung ...

Manufacturing operations divestiture sharpens focus on core capabilities in novel drug discovery and developmentManufacturing divestiture and ...

Joe Macken's fascination with buildings and landscapes started as a child after visiting the Panorama of the City of New York ...

Interstitial lung disease (ILD) represents one of the most severe and clinically impactful manifestations of systemic autoimmune diseases, contributing ...